State Plan Amendment (SPA) 25-0006 High-Cost Drugs is being submitted to allow the Division of Medicaid (DOM) to reimburse certain high-cost drugs outside of the All-Patient Refined Diagnosis Related Group (APR-DRG) reimbursement system, effective January 1, 2025.
For more information, read the proposed SPA pages.
March 27, 2025
Related Articles
-
UPDATE: Conduent pharmacy point-of-sale claims system to shut down on Thursday, Sept. 29, 2022, as part of Fiscal Agent transition
-
IMMEDIATE ACTION REQUIRED: Medicaid Providers must follow instructions for EDI registration and testing to prepare for new Provider Portal
-
Healthier MS Waiver Annual Post-Award Forum
-
Public Notice for 1915 (c) Independent Living (IL) Waiver Renewal
